Related Experiment Video
Updated: Aug 15, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Orally bioavailable highly potent HIV protease inhibitors against PI-resistant virus
Zhijian Lu1, Joann Bohn, Tom Rano
1Department of Basic Chemistry, Merck Research Laboratories, Rahway, NJ 07065, USA. Zhijian_lu@merck.com
Abstract:
Efforts directed to identifying potent HIV protease inhibitors (PI) have yielded a class of compounds that are not only very active against wild-type (NL4-3) HIV virus but also very potent against a panel of PI-resistant viral isolates. Chemistry and biology are described.
Related Concept Videos
Inhibitors of Virion Maturation and Assembly
Antiviral Nucleoside Inhibitors
Retrovirus Life Cycles
Inhibitors of Viral Protein Synthesis
Antiprotozoal Agents
Dipeptidyl Peptidase 4 Inhibitors

